3 ms·
My answer is "we don't know but there seems to be little harm in trying it." This is what's happening right now. Sure, it's a bit of a shotgun approach, but aga
by deelowe 6y ago
My answer is "we don't know but there seems to be little harm in trying it." This is what's happening right now. Sure, it's a bit of a shotgun approach, but again, if Drs want to used an already fda approved drug and try various approaches to see if it helps, I see no issue. Honestly, I don't get all the politics around this.
- pkilgore 6y ago> there seems to be little harm in trying it Do you have a link to that research?
- outworlder 6y agoThere's plenty of possible harm by applying unproven treatments to patients in serious condition. Even if said treatment was deemed to be safe in other instances. Also drug interactions have to be accounted for. It might also exacerbate conditions from this pathology (for instance, further stresses on the cardiovascular system are dangerous for COVID patients). We are not shamans.
- gus_massa 6y ago> ... there seems to be little harm in trying it [...] if Drs want to used an already fda approved drug ... All drugs have side effects, for example https://www.webmd.com/drugs/2/drug-5482/hydroxychloroquine-oral/details https://www.webmd.com/drugs/2/drug-5482/hydroxychloroquine-o... So each drug is a (small) risk for the patient. The idea of testing the drugs in RCT before using in the patients in the wild is that you can be quite sure that the benefits are greater than the risks.